Comparing Cardiovascular Safety Profile Of Anti-Obesity Medications - A FAERS Database Analysis

被引：0
|
作者：
Patel, Riya
Pandya, Krutarth
Shah, Kruti
Bhakta, Shyam
机构：
来源：
OBESITY | 2023年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
429
引用
收藏
页码：225 / 225
页数：1
相关论文
共 50 条
  • [41] The efficacy and safety of novel anti-obesity therapies
    Papazafiropoulou, A. K.
    Papanas, N.
    Melidonis, A.
    ARCHIVES OF HELLENIC MEDICINE, 2015, 32 (03): : 295 - 301
  • [42] ANTI-OBESITY MEDICATIONS ARE UNDERUTILIZED IN TERTIARY ACADEMIC NAFLD CLINIC
    Petrie, Erin
    Aryan, Mahmoud
    Ousley, Robert
    Massoud, Moustafa
    Ravi, Sujan
    Beasley, Mark
    Shoreibah, Mohamed
    Gray, Meagan
    GASTROENTEROLOGY, 2022, 162 (07) : S1272 - S1272
  • [43] PRIMARY CARE PERSPECTIVES ON PRESCRIBING ANTI-OBESITY MEDICATIONS FOR ADOLESCENTS
    Chivate, Rutha
    Schoemer, Pamela
    Ray, Kristin
    Ragavan, Maya
    Bensignor, Megan
    Goldschmidt, Andrea
    Vajravelu, Mary Ellen
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 268 - 270
  • [44] Anti-obesity Medications for the Management of Nonalcoholic Fatty Liver Disease
    Stergios A. Polyzos
    Dimitrios G. Goulis
    Olga Giouleme
    Georgios S. Germanidis
    Antonis Goulas
    Current Obesity Reports, 2022, 11 : 166 - 179
  • [45] Why are we still in need for novel anti-obesity medications?
    Novikoff, Aaron
    Grandl, Gerald
    Liu, Xue
    Mueller, Timo D.
    LANCET REGIONAL HEALTH-EUROPE, 2024, 47
  • [46] EFFECTIVENESS OF ANTI-OBESITY MEDICATIONS IN "REAL WORLD" CLINICAL PRACTICE
    Calderon, Gerardo
    Hurtado, Maria D.
    Valencia, Oscar A. Garcia
    Gonzalez-Izundegui, Daniel
    Sharma, Mayank
    Shah, Meera
    Hurley, Daniel L.
    Abu-Lebdeh, H. S.
    Schmitz, Kristine
    Clark, Matthew
    Grothe, Karen
    Mundi, Manpreet
    Jensen, Michael D.
    Abu Dayyeh, Barham K.
    Collazo-Clavell, Maria L.
    Camilleri, Michael
    Acosta, Andres
    GASTROENTEROLOGY, 2019, 156 (06) : S931 - S931
  • [47] Ischemic colitis after mesotherapy combined with anti-obesity medications
    Jong Bin Kim
    Won Moon
    Seun Ja Park
    Moo In Park
    Kyu-Jong Kim
    Jae Nam Lee
    Seong Joo Kang
    Lee La Jang
    Hee Kyung Chang
    World Journal of Gastroenterology, 2010, 16 (12) : 1537 - 1540
  • [48] Anti-obesity Medications: Ethical, Policy, and Public Health Concerns
    Klitzman, Robert
    Greenberg, Henry
    HASTINGS CENTER REPORT, 2024, 54 (03) : 6 - 10
  • [49] Eligibility for Anti-Obesity Medications through Medicare for Older Adults with Overweight or Obesity
    Chetty, Ashwin K.
    Khunte, Mihir
    Chen, Alissa S.
    Jastreboff, Ania M.
    Krumholz, Harlan M.
    Lu, Yuan
    AMERICAN HEART JOURNAL, 2024, 278
  • [50] Weight a Minute: the Role of Emergent Anti-obesity Medications in the Management of Severe Obesity
    Masrur, Mario A.
    Laos, Emiliano G. Manueli
    Ducas, Alvaro
    Pirzada, Amber
    Schlottmann, Francisco
    OBESITY SURGERY, 2024, 34 (07) : 2685 - 2687
12345